SCFN.webp
The Digest:

According to medical updates from the Sickle Cell Foundation Nigeria (SCFN), a pioneering non-profit bone marrow transplant programme in Lagos is now providing a proven curative treatment for sickle cell disease at a fraction of the international cost. The initiative, a collaboration with Lagos University Teaching Hospital (LUTH), has completed multiple transplants since its launch in 2022.

Key Points:
  • The SCFN-LUTH Bone Marrow Transplant Programme is Africa's first dedicated non-profit effort for sickle cell disease.
  • The procedure, which uses an HLA-identical sibling donor, is the only known permanent cure for sickle cell disease.
  • Local treatment costs between $15,000 and $22,000, compared to $500,000–$800,000 abroad, due to donor support and local infrastructure.
  • The programme reports an approximate 85–90% success rate for eligible patients, particularly children with matched sibling donors.
  • Services include comprehensive care from donor screening and transplant to lifelong follow-up.
  • The centre is located at the Olikoye Ransome-Kuti Children Emergency Centre within LUTH in Lagos.
  • Interested patients or families can contact the programme via WhatsApp (08108188085), mobile (08135190029), or email ([email protected]).
This breakthrough represents a transformative shift in Africa's healthcare landscape, turning a once-distant, prohibitively expensive cure into a tangible, local reality for Nigerians burdened by sickle cell disease.

Sources: Sickle Cell Foundation Nigeria

To view this content we will need your consent to set third party cookies.
For more detailed information, see our cookies page.


To view this content we will need your consent to set third party cookies.
For more detailed information, see our cookies page.